Fidelity Investments’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-10,208
| Closed | -$75.7K | – | 5654 |
|
|
2026
Q1 | $75.7K | Buy |
10,208
+10,000
| +4,808% | +$65.1K | ﹤0.01% | 3922 |
|
|
2025
Q4 | $1.31K | Sell |
208
-8,524
| -98% | -$49.7K | ﹤0.01% | 5072 |
|
|
2025
Q3 | $34.1K | Sell |
8,732
-13,933
| -61% | -$57.1K | ﹤0.01% | 4146 |
|
|
2025
Q2 | $104K | Buy |
22,665
+8,360
| +58% | +$35.8K | ﹤0.01% | 3596 |
|
|
2025
Q1 | $69.8K | Buy |
14,305
+5,904
| +70% | +$35.8K | ﹤0.01% | 3710 |
|
|
2024
Q4 | $56.5K | Buy |
8,401
+8,080
| +2,517% | +$60.2K | ﹤0.01% | 3794 |
|
|
2024
Q3 | $2.48K | Sell |
321
-5,908
| -95% | -$35.6K | ﹤0.01% | 4759 |
|
|
2024
Q2 | $37.4K | Buy |
6,229
+4,020
| +182% | +$30.6K | ﹤0.01% | 3772 |
|
|
2024
Q1 | $19.9K | Buy |
2,209
+358
| +19% | +$3.26K | ﹤0.01% | 4022 |
|
|
2023
Q4 | $17.5K | Buy |
1,851
+1,120
| +153% | +$9.85K | ﹤0.01% | 4009 |
|
|
2023
Q3 | $8.7K | Sell |
731
-3,186
| -81% | -$56.5K | ﹤0.01% | 4156 |
|
|
2023
Q2 | $96K | Sell |
3,917
-163
| -4% | -$4.24K | ﹤0.01% | 3180 |
|
|
2023
Q1 | $128K | Sell |
4,080
-4,473
| -52% | -$259K | ﹤0.01% | 3120 |
|
|
2022
Q4 | $602K | Sell |
8,553
-2,802
| -25% | -$208K | ﹤0.01% | 2663 |
|
|
2022
Q3 | $978K | Buy |
11,355
+26
| +0.2% | +$2.53K | ﹤0.01% | 2612 |
|
|
2022
Q2 | $937K | Buy |
11,329
+7,306
| +182% | +$644K | ﹤0.01% | 2688 |
|
|
2022
Q1 | $669K | Buy |
+4,023
| New | +$577K | ﹤0.01% | 2900 |
|
|
2021
Q2 | – | Sell |
-134,674
| Closed | -$8.03M | – | 4598 |
|
|
2021
Q1 | $8.03M | Sell |
134,674
-51,899
| -28% | -$3.03M | ﹤0.01% | 2115 |
|
|
2020
Q4 | $9.74M | Hold |
186,573
| – | – | ﹤0.01% | 1981 |
|
|
2020
Q3 | $9.03M | Sell |
186,573
-7,180
| -4% | -$343K | ﹤0.01% | 1865 |
|
|
2020
Q2 | $10M | Sell |
193,753
-50,687
| -21% | -$2.56M | ﹤0.01% | 1809 |
|
|
2020
Q1 | $10.7M | Sell |
244,440
-42,685
| -15% | -$1.74M | ﹤0.01% | 1674 |
|
|
2019
Q4 | $11.5M | Buy |
287,125
+5,982
| +2% | +$184K | ﹤0.01% | 1800 |
|
|
2019
Q3 | $9.22M | Sell |
281,143
-5,648
| -2% | -$273K | ﹤0.01% | 1867 |
|
|
2019
Q2 | $22.1M | Buy |
286,791
+11,158
| +4% | +$1.74M | ﹤0.01% | 1581 |
|
|
2019
Q1 | $48.9M | Sell |
275,633
-9,290
| -3% | -$1.83M | 0.01% | 1226 |
|
|
2018
Q4 | $67.2M | Buy |
284,923
+31,885
| +13% | +$7.79M | 0.01% | 1031 |
|
|
2018
Q3 | $54.2M | Buy |
253,038
+102,780
| +68% | +$17.9M | 0.01% | 1234 |
|
|
2018
Q2 | $26M | Buy |
+150,258
| New | +$26.2M | ﹤0.01% | 1605 |
|
Fidelity Investments's KZR Position: Q2 2026 in Review
Fidelity Investments sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 10,208 shares — an estimated $75.7K sold.
Fidelity Investments first reported a position in KZR in Q2 2018 and held it in 29 quarters. The position peaked at $67.2M in Q4 2018. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.
- Fidelity Investments reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
- Fidelity Investments sold 10,208 Kezar Life Sciences shares in Q2 2026, an estimated $75.7K.
- Fidelity Investments first reported a position in Kezar Life Sciences in Q2 2018 and held it in 29 quarters.
- Fidelity Investments's Kezar Life Sciences position peaked at $67.2M in Q4 2018.
- 0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.